{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:25:06Z","timestamp":1786551906172,"version":"build-2736575974"},"reference-count":307,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CTSA","award":["KL2 TR001112"],"award-info":[{"award-number":["KL2 TR001112"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.trsl.2016.02.011","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T09:09:12Z","timestamp":1456391352000},"page":"98-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Emerging concepts: mast cell involvement in allergic diseases"],"prefix":"10.1016","volume":"174","author":[{"given":"Brian D.","family":"Modena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Dazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-9008","authenticated-orcid":false,"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2016.02.011_bib1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.162.3.1025","volume":"162","author":"Nakano","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri1460","article-title":"Mast-cell responses to pathogens","volume":"4","author":"Marshall","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60508-8","article-title":"The kit ligand, stem cell factor","volume":"55","author":"Galli","year":"1994","journal-title":"Adv Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1568010033483990","article-title":"Stem cell factor: a hemopoietic cytokine with important targets in asthma","volume":"2","author":"Oliveira","year":"2003","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejphar.2005.12.067","article-title":"Stem cell factor and its receptor c-Kit as targets for inflammatory diseases","volume":"533","author":"Reber","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2016.02.011_bib6","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.4049\/jimmunol.147.12.4224","article-title":"IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells","volume":"147","author":"Sillaber","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/blood.V91.1.187","article-title":"Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation","volume":"91","author":"Toru","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.02.011_bib8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/intimm\/8.9.1367","article-title":"Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4","volume":"8","author":"Toru","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib9","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1073\/pnas.88.8.3339","article-title":"Interleukin 4 promotes expression of mast cell ICAM-1 antigen","volume":"88","author":"Valent","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.02.011_bib10","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.170.7.3461","article-title":"IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor","volume":"170","author":"Matsuzawa","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib11","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.4049\/jimmunol.166.7.4672","article-title":"An increase in circulating mast cell colony-forming cells in asthma","volume":"166","author":"Mwamtemi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1189\/jlb.0405201","article-title":"Interleukin-10 induces apoptosis in developing mast cells and macrophages","volume":"80","author":"Bailey","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.trsl.2016.02.011_bib13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1365-2222.2001.01069.x","article-title":"Inhibition of IgE-induced activation of human mast cells by IL-10","volume":"31","author":"Royer","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.192.8.1093","article-title":"Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis","volume":"192","author":"Yeatman","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib15","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1189\/jlb.0407200","article-title":"IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals","volume":"82","author":"Ho","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.trsl.2016.02.011_bib16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/labinvest.3700663","article-title":"IL-33 can promote survival, adhesion and cytokine production in human mast cells","volume":"87","author":"Iikura","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2016.02.011_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2007.05.046","article-title":"H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12","volume":"120","author":"Godot","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4049\/jimmunol.165.1.211","article-title":"Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha","volume":"165","author":"Lin","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib19","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.4049\/jimmunol.0903477","article-title":"IL-4 and TGF-beta 1 counterbalance one another while regulating mast cell homeostasis","volume":"184","author":"Macey","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.174.1.7","article-title":"Nerve growth factor induces development of connective tissue-type mast cells in\u00a0vitro from murine bone marrow cells","volume":"174","author":"Matsuda","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2015.04.046","article-title":"Mast cells in airway diseases and interstitial lung disease","volume":"778","author":"Cruse","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2016.02.011_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.immuni.2012.09.022","article-title":"Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E","volume":"38","author":"Cheng","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2016.02.011_bib23","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.1203420","article-title":"Innate immunity and its regulation by mast cells","volume":"190","author":"St John","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.coi.2009.09.007","article-title":"New roles for mast cells in modulating allergic reactions and immunity against pathogens","volume":"21","author":"Hofmann","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0952-7915(99)80010-7","article-title":"Mast cells as sentinels of innate immunity","volume":"11","author":"Galli","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cea.12176","article-title":"Mapping of TLR5 and TLR7 in central and distal human airways and identification of reduced TLR expression in severe asthma","volume":"44","author":"Shikhagaie","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1183\/09031936.98.11040958","article-title":"Plasma-derived proteins in airway defence, disease and repair of epithelial injury","volume":"11","author":"Persson","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trsl.2016.02.011_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/713773924","article-title":"Endothelial gaps as sites for plasma leakage in inflammation","volume":"6","author":"McDonald","year":"1999","journal-title":"Microcirculation"},{"key":"10.1016\/j.trsl.2016.02.011_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.20050959","article-title":"Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization","volume":"202","author":"Heissig","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib31","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1096\/fj.06-5837fje","article-title":"Mast cells are required for normal healing of skin wounds in mice","volume":"20","author":"Weller","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2016.02.011_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.it.2007.03.003","article-title":"Mast cells\u2013key effector cells in immune responses","volume":"28","author":"Metz","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u201ctunable\u201d effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib34","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1046\/j.1365-2222.1999.00636.x","article-title":"Interleukin-10 is localized to and released by human lung mast cells","volume":"29","author":"Ishizuka","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ajpath.2012.05.013","article-title":"The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis","volume":"181","author":"Piliponsky","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.02.011_bib36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1515\/hsz-2012-0189","article-title":"Mast cells limit extracellular levels of IL-13 via a serglycin proteoglycan-serine protease axis","volume":"393","author":"Waern","year":"2012","journal-title":"Biol Chem"},{"key":"10.1016\/j.trsl.2016.02.011_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0091-6749(05)80120-4","article-title":"Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis","volume":"86","author":"Irani","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2011.09.007","article-title":"The role of mast cells in allergic inflammation","volume":"106","author":"Amin","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib39","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI19785","article-title":"Mast cells are required for experimental oral allergen-induced diarrhea","volume":"112","author":"Brandt","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.02.011_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1440-1711.2001.00983.x","article-title":"Regulation of the inflammatory response in asthma by mast cell products","volume":"79","author":"Hart","year":"2001","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.trsl.2016.02.011_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.it.2004.10.010","article-title":"Mast cells and basophils: friends as well as foes in bronchial asthma?","volume":"26","author":"Marone","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib42","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/thorax.58.6.528","article-title":"Comparison of airway immunopathology of eosinophilic bronchitis and asthma","volume":"58","author":"Brightling","year":"2003","journal-title":"Thorax"},{"issue":"22","key":"10.1016\/j.trsl.2016.02.011_bib43","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa012705","article-title":"Mast-cell infiltration of airway smooth muscle in asthma","volume":"346","author":"Brightling","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.intimp.2010.12.008","article-title":"Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis","volume":"11","author":"Cho","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2016.02.011_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/003655201750065933","article-title":"Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease","volume":"36","author":"Raithel","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.02.011_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-3024.1999.00200.x","article-title":"Mast cells, eosinophils and antibody-mediated cellular cytotoxicity are not critical in resistance to Trichuris muris","volume":"21","author":"Betts","year":"1999","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/32190","article-title":"Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites","volume":"392","author":"Lantz","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.02.011_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/path.1780","article-title":"c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases","volume":"206","author":"Edwards","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.trsl.2016.02.011_bib49","first-page":"717","article-title":"Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders","volume":"40","author":"Kawanami","year":"1979","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2016.02.011_bib50","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma","volume":"172","author":"Yoshizaki","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.02.011_bib51","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.4049\/jimmunol.1300875","article-title":"Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymase\/mast cell protease 4-dependent mechanism","volume":"192","author":"Reber","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/mi.2014.131","article-title":"Potential effector and immunoregulatory functions of mast cells in mucosal immunity","volume":"8","author":"Reber","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib53","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.transproceed.2013.01.078","article-title":"Mast cell quantitation in renal transplant biopsy specimens as a potential marker for the cumulative burden of tissue injury","volume":"45","author":"Papadimitriou","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trsl.2016.02.011_bib54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/apm.1966.66.3.289","article-title":"Mast cells in rat gastrointestinal mucosa. I. Effects of fixation","volume":"66","author":"Enerback","year":"1966","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.trsl.2016.02.011_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2222.1989.tb02357.x","article-title":"Mast cell heterogeneity","volume":"19","author":"Irani","year":"1989","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1183\/09059180.00005014","article-title":"Mast cells in human airways: the culprit?","volume":"23","author":"Erjefalt","year":"2014","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.trsl.2016.02.011_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4049\/jimmunol.147.1.247","article-title":"Human mast cell carboxypeptidase. Selective localization to MCTC cells","volume":"147","author":"Irani","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib58","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1073\/pnas.83.12.4464","article-title":"Two types of human mast cells that have distinct neutral protease compositions","volume":"83","author":"Irani","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.02.011_bib59","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1177\/37.10.2674273","article-title":"Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies","volume":"37","author":"Irani","year":"1989","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.trsl.2016.02.011_bib60","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.145.8.2652","article-title":"Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell","volume":"145","author":"Schechter","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib61","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.4049\/jimmunol.164.12.6566","article-title":"Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families","volume":"164","author":"Caughey","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib62","doi-asserted-by":"crossref","first-page":"30784","DOI":"10.1074\/jbc.274.43.30784","article-title":"Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension","volume":"274","author":"Wong","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.02.011_bib63","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.4049\/jimmunol.154.10.5472","article-title":"Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction","volume":"154","author":"Xia","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0344-0338(11)80086-5","article-title":"Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content","volume":"189","author":"Weidner","year":"1993","journal-title":"Pathol Res Pract"},{"issue":"Suppl","key":"10.1016\/j.trsl.2016.02.011_bib65","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1513\/AnnalsATS.201303-064AW","article-title":"Mast cells, their subtypes, and relation to asthma phenotypes","volume":"10","author":"Fajt","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.trsl.2016.02.011_bib66","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/40.6.1588024","article-title":"Distribution of chymase-containing mast cells in human bronchi","volume":"40","author":"Matin","year":"1992","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.trsl.2016.02.011_bib67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/thx.2008.101683","article-title":"Novel site-specific mast cell subpopulations in the human lung","volume":"64","author":"Andersson","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.trsl.2016.02.011_bib68","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.jaci.2014.12.1929","article-title":"Intracellular residency of Staphylococcus aureus within mast cells in nasal polyps: a novel observation","volume":"135","author":"Hayes","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib69","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1172\/JCI112937","article-title":"Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness","volume":"79","author":"Casale","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.02.011_bib70","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm\/137.5.1002","article-title":"Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In\u00a0vivo release of histamine and tryptase in atopic subjects with and without asthma","volume":"137","author":"Wenzel","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib71","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0091-6749(91)90013-E","article-title":"Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses","volume":"87","author":"Wenzel","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib72","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198609253151304","article-title":"Release of prostaglandin D2 into human airways during acute antigen challenge","volume":"315","author":"Murray","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib73","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1164\/ajrccm\/136.5.1140","article-title":"Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma","volume":"136","author":"Beasley","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1164\/ajrccm\/142.1.112","article-title":"Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge","volume":"142","author":"Wenzel","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib75","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.00106306","article-title":"Histamine and tryptase modulate asthmatic airway smooth muscle GM-CSF and RANTES release","volume":"29","author":"Chhabra","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trsl.2016.02.011_bib76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/ajrccm\/144.1.83","article-title":"Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction","volume":"144","author":"Jarjour","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI113855","article-title":"Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs","volume":"83","author":"Sekizawa","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.02.011_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1165\/ajrcmb\/3.1.27","article-title":"Degradation of airway neuropeptides by human lung tryptase","volume":"3","author":"Tam","year":"1990","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2016.02.011_bib79","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0022-3565(25)24170-2","article-title":"Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret","volume":"248","author":"Franconi","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2016.02.011_bib80","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1165\/ajrcmb\/2.5.449","article-title":"Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi","volume":"2","author":"Tam","year":"1990","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2016.02.011_bib81","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/ajrccm\/145.6.1281","article-title":"The effects of lipoxin A4 on airway responses in asthmatic subjects","volume":"145","author":"Christie","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib82","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/thx.38.9.668","article-title":"Histamine bronchial challenge: effect on regional ventilation and aerosol deposition","volume":"38","author":"Clague","year":"1983","journal-title":"Thorax"},{"key":"10.1016\/j.trsl.2016.02.011_bib83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2500\/108854197778612817","article-title":"Airway responsiveness in asthma: bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide","volume":"18","author":"du Toit","year":"1997","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.trsl.2016.02.011_bib84","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thx.52.6.513","article-title":"Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4","volume":"52","author":"Sampson","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.trsl.2016.02.011_bib85","first-page":"181","article-title":"Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways","volume":"135","author":"Rafferty","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib86","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/thx.42.12.946","article-title":"Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man","volume":"42","author":"Curzen","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.trsl.2016.02.011_bib87","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0140-6736(91)90277-V","article-title":"Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects","volume":"337","author":"Taylor","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2016.02.011_bib88","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0091-6749(92)90227-S","article-title":"Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma","volume":"89","author":"Findlay","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib89","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1164\/ajrccm.155.6.9196083","article-title":"Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response","volume":"155","author":"Boulet","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib90","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1164\/ajrccm.155.6.9196082","article-title":"The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects","volume":"155","author":"Fahy","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib91","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2222.1977.tb01481.x","article-title":"Allergen-induced increase in non-allergic bronchial reactivity","volume":"7","author":"Cockcroft","year":"1977","journal-title":"Clin Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1165\/ajrcmb\/8.1.35","article-title":"Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte\/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics","volume":"8","author":"Bentley","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2016.02.011_bib93","first-page":"373","article-title":"Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions","volume":"131","author":"De Monchy","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib94","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1164\/ajrccm\/139.6.1383","article-title":"Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions","volume":"139","author":"Diaz","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib95","first-page":"433","article-title":"Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation","volume":"135","author":"Metzger","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib96","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1172\/JCI117118","article-title":"Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways","volume":"93","author":"Montefort","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.02.011_bib97","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(83)92356-5","article-title":"Stimulation of alveolar macrophages in asthmatic patients after local provocation test","volume":"1","author":"Tonnel","year":"1983","journal-title":"Lancet"},{"issue":"4 Pt 2","key":"10.1016\/j.trsl.2016.02.011_bib98","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0091-6749(05)80222-2","article-title":"Tryptase, a mediator of human mast cells","volume":"86","author":"Schwartz","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib99","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI115330","article-title":"Mast cell tryptase is a mitogen for cultured fibroblasts","volume":"88","author":"Ruoss","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.02.011_bib100","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.4049\/jimmunol.158.5.2310","article-title":"Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis","volume":"158","author":"Gruber","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib101","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1152\/jappl.2001.91.3.1372","article-title":"Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells","volume":"91","author":"Berger","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.trsl.2016.02.011_bib102","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI119290","article-title":"Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts","volume":"99","author":"Cairns","year":"1997","journal-title":"J Clin Invest"},{"issue":"6 Pt 1","key":"10.1016\/j.trsl.2016.02.011_bib103","first-page":"L365","article-title":"Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression","volume":"259","author":"Panettieri","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.trsl.2016.02.011_bib104","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","article-title":"Cytokine mediated tissue fibrosis","volume":"1832","author":"Borthwick","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2016.02.011_bib105","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","article-title":"The role of the mast cell in the pathophysiology of asthma","volume":"117","author":"Bradding","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib106","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood.V83.12.3600.3600","article-title":"Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in\u00a0vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry","volume":"83","author":"Dvorak","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.02.011_bib107","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.2007.00519.x","article-title":"Differential release of mast cell mediators and the pathogenesis of inflammation","volume":"217","author":"Theoharides","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2016.02.011_bib108","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1365-2222.2011.03852.x","article-title":"IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells","volume":"41","author":"Kanoh","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib109","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ni.2617","article-title":"TH2, allergy and group 2 innate lymphoid cells","volume":"14","author":"Licona-Limon","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molmed.2004.08.004","article-title":"Interleukin-4 receptor signaling pathways in asthma pathogenesis","volume":"10","author":"Chatila","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib111","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.4049\/jimmunol.174.12.7716","article-title":"IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13","volume":"174","author":"Fish","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib112","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","article-title":"Requirement for IL-13 independently of IL-4 in experimental asthma","volume":"282","author":"Grunig","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.trsl.2016.02.011_bib113","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568010023344661","article-title":"IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies","volume":"1","author":"Izuhara","year":"2002","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib114","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib115","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in\u00a0vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2016.02.011_bib116","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","article-title":"The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells","volume":"37","author":"Hoyler","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2016.02.011_bib117","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.2208","article-title":"Ror\u03b1 is essential for nuocyte development","volume":"13","author":"Wong","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib118","first-page":"1","article-title":"Group 2 innate lymphoid cells: new players in human allergic diseases","volume":"25","author":"Doherty","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib119","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mjosberg","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib120","doi-asserted-by":"crossref","first-page":"174ra26","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib121","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib122","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib123","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","article-title":"Enhanced innate type 2 immune response in peripheral blood from patients with asthma","volume":"134","author":"Bartemes","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib124","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaci.2013.09.020","article-title":"Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis","volume":"133","author":"Chang","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib125","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib126","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ni.2133","article-title":"An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation","volume":"12","author":"Wilhelm","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib127","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ni.2584","article-title":"Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells","volume":"14","author":"Roediger","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib128","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4049\/jimmunol.147.4.1387","article-title":"Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis","volume":"147","author":"Madden","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib129","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2002-12-3929","article-title":"Identification of specific gene expression profiles in human mast cells mediated by toll-like receptor 4 and FcepsilonRI","volume":"102","author":"Okumura","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.02.011_bib130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.201002-0295OC","article-title":"Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program","volume":"183","author":"Balzar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-065X.2007.00512.x","article-title":"Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation","volume":"217","author":"Boyce","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2016.02.011_bib132","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.138.8.2611","article-title":"Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells","volume":"138","author":"Schwartz","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib133","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1164\/ajrccm.153.2.8564096","article-title":"Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa","volume":"153","author":"Bentley","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib134","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib136","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.201406-1099OC","article-title":"Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways","volume":"190","author":"Modena","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib137","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jaci.2013.11.042","article-title":"Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data","volume":"133","author":"Wu","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib138","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1183\/09031936.02.00275802","article-title":"Distribution and degranulation of airway mast cells in normal and asthmatic subjects","volume":"19","author":"Carroll","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trsl.2016.02.011_bib139","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaci.2010.03.003","article-title":"Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma","volume":"125","author":"Dougherty","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0091-6749(91)90160-P","volume":"88","author":"Bradley","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib141","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.rmed.2006.10.001","article-title":"Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD","volume":"101","author":"Liesker","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"Molderings","year":"2011","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2016.02.011_bib143","first-page":"1523","article-title":"[Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options]","volume":"139","author":"Molderings","year":"2014","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.trsl.2016.02.011_bib144","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s002510000185","article-title":"Evidence for association and linkage between atopy, airway hyper-responsiveness, and the beta subunit Glu237Gly variant of the high-affinity receptor for immunoglobulin E in the French-Canadian population","volume":"51","author":"Laprise","year":"2000","journal-title":"Immunogenetics"},{"key":"10.1016\/j.trsl.2016.02.011_bib145","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s004390100561","article-title":"Association between nasal allergy and a coding variant of the Fc epsilon RI beta gene Glu237Gly in a Japanese population","volume":"109","author":"Nagata","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.trsl.2016.02.011_bib146","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jaci.2006.04.015","article-title":"Molecular regulation of mast cell activation","volume":"117","author":"Rivera","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib147","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng0694-125","article-title":"Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor","volume":"7","author":"Shirakawa","year":"1994","journal-title":"Nat Genet"},{"issue":"6 Suppl","key":"10.1016\/j.trsl.2016.02.011_bib148","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2004.09.029","article-title":"Rhinosinusitis: establishing definitions for clinical research and patient care","volume":"114","author":"Meltzer","year":"2004","journal-title":"The J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib149","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/000348941112000701","article-title":"Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States","volume":"120","author":"Bhattacharyya","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.trsl.2016.02.011_bib150","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1398-9995.2006.01132.x","article-title":"Distinct features of chronic rhinosinusitis with and without nasal polyps","volume":"61","author":"Polzehl","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib151","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.alit.2014.12.006","article-title":"Immunopathology of chronic rhinosinusitis","volume":"64","author":"Kato","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.trsl.2016.02.011_bib152","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2500\/ajra.2013.27.3981","article-title":"Epidemiology and differential diagnosis of nasal polyps","volume":"27","author":"Chaaban","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib153","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","article-title":"Differentiation of chronic sinus diseases by measurement of inflammatory mediators","volume":"61","author":"Van Zele","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib154","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11882-012-0250-y","article-title":"Pathogenesis and management of nasal polyposis in cystic fibrosis","volume":"12","author":"Mainz","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.trsl.2016.02.011_bib156","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pedex.2009.09.003","article-title":"Nasal polyposis in atypical cystic fibrosis: a case report","volume":"5","author":"Mesolella","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol Extra"},{"key":"10.1016\/j.trsl.2016.02.011_bib157","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/00005537-199608000-00018","article-title":"Patterns of sinusitis in cystic fibrosis","volume":"106","author":"Gentile","year":"1996","journal-title":"Laryngoscope"},{"issue":"8 Pt 1","key":"10.1016\/j.trsl.2016.02.011_bib158","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1164\/ajrccm.164.8.2104075","article-title":"Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction","volume":"164","author":"Sagel","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib159","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ppul.1950200203","article-title":"The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis","volume":"20","author":"Balough","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.trsl.2016.02.011_bib160","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib161","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2273.1997.00003.x","article-title":"Polypoidal rhinosinusitis in cystic fibrosis: a clinical and histopathological study","volume":"22","author":"Rowe-Jones","year":"1997","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.trsl.2016.02.011_bib162","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1378\/chest.115.2.364","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole","volume":"115","author":"Nepomuceno","year":"1999","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2016.02.011_bib163","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.2500\/aap.2012.33.3537","article-title":"Chapter 7: nasal polyps","volume":"33","author":"Georgy","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.trsl.2016.02.011_bib164","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1398-9995.2004.00621.x","article-title":"Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue","volume":"60","author":"Gevaert","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib165","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1017\/S0022215100135388","article-title":"Increase in epithelial mast cell numbers in the nasal mucosa of patients with perennial allergic rhinitis","volume":"110","author":"Slater","year":"1996","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.trsl.2016.02.011_bib166","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1398-9995.1990.tb00513.x","article-title":"The increased number of epithelial mast cells in nasal polyps and adjacent turbinates is not allergy-dependent","volume":"45","author":"Ruhno","year":"1990","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib167","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1046\/j.1365-2222.1999.00608.x","article-title":"Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: a comparison of nasal brush and biopsy methods","volume":"29","author":"Jacobson","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib168","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/ajrccm.164.5.2006082","article-title":"Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa","volume":"164","author":"Braunstahl","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib169","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000237429","article-title":"Existence of c-kit receptor-positive, tryptase-negative, IgE-negative cells in human allergic nasal mucosa: a candidate for mast cell progenitor","volume":"112","author":"Kawabori","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib170","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0091-6749(95)70177-X","article-title":"Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects","volume":"95","author":"Igarashi","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib171","first-page":"597","article-title":"Mediator release after nasal airway challenge with allergen","volume":"128","author":"Naclerio","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"2 Pt 2","key":"10.1016\/j.trsl.2016.02.011_bib172","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0091-6749(85)90656-6","article-title":"Role of human basophils and mast cells in the pathogenesis of allergic diseases","volume":"76","author":"Schleimer","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib173","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2500\/105065887781693420","article-title":"Nasal polyps: epidemiology, pathology, immunology, and treatment","volume":"1","author":"Settipane","year":"1987","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.trsl.2016.02.011_bib174","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1385\/CRIAI:24:2:169","article-title":"Pathogenesis of aspirin-exacerbated respiratory disease","volume":"24","author":"Stevenson","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib175","first-page":"15","article-title":"Etiology of nasal polyps associated with aspirin-sensitive asthma","volume":"8","author":"Yamashita","year":"1989","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.trsl.2016.02.011_bib176","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000053811","article-title":"Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis","volume":"125","author":"Di Lorenzo","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib177","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","article-title":"Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial","volume":"387","author":"Tha\u00e7i","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2016.02.011_bib178","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ai.2014.09.002","article-title":"Mast cells' integrated actions with eosinophils and fibroblasts in allergic inflammation: implications for therapy","volume":"125","author":"Landolina","year":"2015","journal-title":"Adv Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib179","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0091-6749(95)70298-9","article-title":"Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis","volume":"96","author":"Hamilos","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1398-9995.2006.01255.x","article-title":"Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps","volume":"62","author":"Chen","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib181","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.anai.2013.06.023","article-title":"Expression of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 1 in nonrecurrent vs recurrent nasal polyps","volume":"111","author":"Yeo","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib182","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3346\/jkms.2003.18.1.97","article-title":"Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1","volume":"18","author":"Lee","year":"2003","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.trsl.2016.02.011_bib183","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000087639","article-title":"Mast cells in allergic airway disease and chronic rhinosinusitis","volume":"87","author":"Pawankar","year":"2005","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib184","first-page":"93","article-title":"Role of mast cells and basophils in chronic rhinosinusitis","volume":"20","author":"Pawankar","year":"2007","journal-title":"Clin Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib185","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2222.2004.1954.x","article-title":"Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts","volume":"34","author":"Nonaka","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib186","series-title":"Histamine research in the new millennium","first-page":"369","article-title":"Mast cells in rhinitis","author":"Pawankar","year":"2001"},{"key":"10.1016\/j.trsl.2016.02.011_bib187","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2012.02.046","article-title":"Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps","volume":"130","author":"Takabayashi","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib188","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/cea.12304","article-title":"Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps","volume":"44","author":"Cao","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib189","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11882-002-0027-9","article-title":"Staphylococcus aureus superantigens and airway disease","volume":"2","author":"Bachert","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.trsl.2016.02.011_bib190","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2004.08.012","article-title":"Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi","volume":"114","author":"Shin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib191","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib192","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1365-2222.2004.01989.x","article-title":"In\u00a0vitro diagnosis of chronic nasal inflammation","volume":"34","author":"Kramer","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib193","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.4049\/jimmunol.170.4.1854","article-title":"Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chains of IgE","volume":"170","author":"Genovese","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib194","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1128\/IAI.68.10.5517-5524.2000","article-title":"Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E","volume":"68","author":"Genovese","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.trsl.2016.02.011_bib195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000073709","article-title":"Toll-like receptor-mediated activation of mast cells: implications for allergic disease?","volume":"132","author":"Marshall","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib196","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fimmu.2012.00185","article-title":"TLR signaling in mast cells: common and unique features","volume":"3","author":"Sandig","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib197","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/CRIAI:22:2:189","article-title":"Regulation of mast cell-mediated innate immunity during early response to bacterial infection","volume":"22","author":"Malaviya","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib198","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.4049\/jimmunol.169.7.3801","article-title":"Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways","volume":"169","author":"Masuda","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib199","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20062211","article-title":"Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells","volume":"204","author":"Allakhverdi","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaci.2012.04.019","article-title":"Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin","volume":"130","author":"Nagarkar","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib201","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib202","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","article-title":"Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma","volume":"6","author":"Sladek","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trsl.2016.02.011_bib203","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib204","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1164\/ajrccm.155.4.9105094","article-title":"Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium","volume":"155","author":"Robuschi","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1081-1206(10)62951-1","article-title":"Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma","volume":"80","author":"Yoshida","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib206","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.clinbiochem.2012.12.005","article-title":"Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD)","volume":"46","author":"Narayanankutty","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.trsl.2016.02.011_bib207","article-title":"Protective effects of prostaglandin E2 (PGE2) on airway obstruction induced by aspirin (ASA) in aspirin-intolerant asthmatics (AIA)","volume":"Suppl 18","author":"Mastalerz","year":"1994","journal-title":"European Respiratory Journal - Supplement [Internet]"},{"key":"10.1016\/j.trsl.2016.02.011_bib208","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 Pt 1","key":"10.1016\/j.trsl.2016.02.011_bib209","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib210","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1164\/ajrccm\/137.4.847","article-title":"Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin","volume":"137","author":"Ferreri","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.02.011_bib211","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1165\/rcmb.2014-0486OC","article-title":"Impaired EP expression causes resistance to prostaglandin E in nasal polyp fibroblasts from subjects with AERD","volume":"54","author":"Cahill","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2016.02.011_bib212","doi-asserted-by":"crossref","first-page":"e108595","DOI":"10.1371\/journal.pone.0108595","article-title":"Expression of DP2 (CRTh2), a prostaglandin D(2) receptor, in human mast cells","volume":"9","author":"Moon","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2016.02.011_bib213","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000334555","article-title":"The potential role of prostaglandin D2 in nasal congestion observed in a guinea pig model of allergic rhinitis","volume":"158","author":"Takahashi","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib214","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.4049\/jimmunol.174.6.3703","article-title":"Activation of the prostaglandin D2 receptor DP2\/CRTH2 increases allergic inflammation in mouse","volume":"174","author":"Spik","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib216","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/ACI.0b013e328357a21b","article-title":"Molecular immunology of allergic conjunctivitis","volume":"12","author":"Irkec","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib217","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib218","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e32834a9652","article-title":"Ocular allergy","volume":"11","author":"Friedlaender","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib219","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clae.2008.07.003","article-title":"The pathophysiology of ocular allergy: a review","volume":"32","author":"Chigbu","year":"2009","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.trsl.2016.02.011_bib220","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1167\/iovs.11-8748","article-title":"Role of histamine and its receptor subtypes in stimulation of conjunctival goblet cell secretion","volume":"53","author":"Hayashi","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.trsl.2016.02.011_bib221","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4419-8056-4_5","article-title":"The role of histamine in ocular allergy","volume":"709","author":"Ohbayashi","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2016.02.011_bib222","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2008.03716.x","article-title":"Allergy and the eye","volume":"153","author":"Leonardi","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib223","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/02713683.2012.747617","article-title":"New twists to an old story: novel concepts in the pathogenesis of allergic eye disease","volume":"38","author":"Saban","year":"2013","journal-title":"Curr Eye Res"},{"issue":"3 Pt 1","key":"10.1016\/j.trsl.2016.02.011_bib224","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0091-6749(88)90020-6","article-title":"Inflammatory changes in conjunctival scrapings after allergen provocation in humans","volume":"82","author":"Bonini","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib225","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaci.2007.04.024","article-title":"Development of eosinophilic conjunctival inflammation at late-phase reaction in mast cell-deficient mice","volume":"120","author":"Ueta","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib226","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11882-002-0061-7","article-title":"The central role of conjunctival mast cells in the pathogenesis of ocular allergy","volume":"2","author":"Leonardi","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.trsl.2016.02.011_bib227","first-page":"995","article-title":"The relative contribution of mast cell subsets to conjunctival TH2-like cytokines","volume":"42","author":"Anderson","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.trsl.2016.02.011_bib228","first-page":"336","article-title":"Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-alpha from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells","volume":"39","author":"Cook","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.trsl.2016.02.011_bib229","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2013.10.036","article-title":"Atopic keratoconjunctivitis: a review","volume":"70","author":"Chen","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2016.02.011_bib230","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1398-9995.2011.02612.x","article-title":"Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis","volume":"66","author":"Leonardi","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib231","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.all.0000183113.63311.11","article-title":"Histamine receptors and the conjunctiva","volume":"5","author":"Bielory","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib232","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1076\/ceyr.25.3.189.13479","article-title":"Histamine-induced cytokine production and ICAM-1 expression in human conjunctival fibroblasts","volume":"25","author":"Leonardi","year":"2002","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.trsl.2016.02.011_bib233","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-9394(14)76821-7","article-title":"Number of inflammatory cells in the normal conjunctiva","volume":"86","author":"Allansmith","year":"1978","journal-title":"Am J Ophthalmol"},{"issue":"1 Pt 1","key":"10.1016\/j.trsl.2016.02.011_bib234","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0091-6749(91)90221-9","article-title":"Mast cell numbers and staining characteristics in the normal and allergic human conjunctiva","volume":"87","author":"Morgan","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib235","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1365-2222.1997.tb01258.x","article-title":"Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration","volume":"27","author":"Anderson","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib236","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib237","first-page":"9","article-title":"The epidemiology of atopic dermatitis","volume":"31","author":"Schultz Larsen","year":"1993","journal-title":"Monogr Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib238","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2310\/6620.2007.06034","article-title":"A population-based survey of eczema prevalence in the United States","volume":"18","author":"Hanifin","year":"2007","journal-title":"Dermatitis"},{"key":"10.1016\/j.trsl.2016.02.011_bib239","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/all.12526","article-title":"Mast cells and basophils in cutaneous immune responses","volume":"70","author":"Otsuka","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib240","series-title":"Middleton's allergy: principles and practice","first-page":"1083","article-title":"Atopic dermatitis","author":"Boguniewicz","year":"2009"},{"key":"10.1016\/j.trsl.2016.02.011_bib241","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaci.2012.12.672","article-title":"Atopic dermatitis: a practice parameter update 2012","volume":"131","author":"Schneider","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib242","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.02.001","article-title":"New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity","volume":"70","author":"Kabashima","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.trsl.2016.02.011_bib243","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaci.2013.07.027","article-title":"Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression","volume":"133","author":"Otsuka","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib244","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2353\/ajpath.2010.090957","article-title":"Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract","volume":"176","author":"Moniaga","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.02.011_bib245","series-title":"Manual of Allergy and Immunology","first-page":"494","article-title":"Atopic dermatitis and contact dermatitis","author":"Boguniewicz","year":"2012"},{"key":"10.1016\/j.trsl.2016.02.011_bib246","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2005.02.014","article-title":"Failure of omalizumab for treatment of severe adult atopic dermatitis","volume":"53","author":"Krathen","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2016.02.011_bib247","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2005.09.030","article-title":"Treatment of recalcitrant atopic dermatitis with omalizumab","volume":"54","author":"Lane","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2016.02.011_bib248","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib249","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2133.1997.tb03927.x","article-title":"Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema","volume":"136","author":"Jarvikallio","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.trsl.2016.02.011_bib250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1398-9995.1989.tb02452.x","article-title":"Mast cells in atopic dermatitis*","volume":"44","author":"Irani","year":"1989","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib251","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0625.1994.tb00291.x","article-title":"Analysis of mast cell subpopulations (MCT, MCTC) in cutaneous inflammation using novel enzyme-histochemical staining techniques","volume":"3","author":"Algermissen","year":"1994","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.trsl.2016.02.011_bib252","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","article-title":"Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis","volume":"60","author":"Oldhoff","year":"2005","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.trsl.2016.02.011_bib253","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.02.011_bib254","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/PL00013776","article-title":"Heterogeneity of dermal deposition of eosinophil granule major basic protein in acute lesions of atopic dermatitis","volume":"292","author":"Omoto","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.trsl.2016.02.011_bib255","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/intimm\/dxp031","article-title":"Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2)","volume":"21","author":"Boehme","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxn118","article-title":"Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms","volume":"21","author":"Boehme","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib257","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/dxn127","article-title":"A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation","volume":"21","author":"Boehme","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib258","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4049\/jimmunol.177.4.2621","article-title":"Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor","volume":"177","author":"Satoh","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib259","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/all.12051","article-title":"Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model","volume":"68","author":"Gschwandtner","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0705729","article-title":"Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation","volume":"142","author":"Ling","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2016.02.011_bib261","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.102.046581","article-title":"Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells","volume":"305","author":"Hofstra","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2016.02.011_bib262","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib263","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaci.2008.05.047","article-title":"Correlation of IL-31 serum levels with severity of atopic dermatitis","volume":"122","author":"Raap","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib264","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9899.1000110","article-title":"Th2 cytokines and atopic dermatitis","volume":"2","author":"Brandt","year":"2011","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib265","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib266","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4049\/jimmunol.0900712","article-title":"Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells","volume":"184","author":"Niyonsaba","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib267","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/ACI.0b013e328364ddfd","article-title":"Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions","volume":"13","author":"Kopfnagel","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib268","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib269","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13601-015-0076-5","article-title":"The role of IL-33 and mast cells in allergy and inflammation","volume":"5","author":"Saluja","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib271","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1093\/hmg\/ddi323","article-title":"Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis","volume":"14","author":"Shimizu","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2016.02.011_bib272","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/jid.2011.446","article-title":"IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors","volume":"132","author":"Savinko","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.02.011_bib273","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/jid.2012.185","article-title":"Regulation of IL-33 expression by IFN-gamma and tumor necrosis factor-alpha in normal human epidermal keratinocytes","volume":"132","author":"Meephansan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.02.011_bib274","doi-asserted-by":"crossref","first-page":"13921","DOI":"10.1073\/pnas.1307321110","article-title":"Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice","volume":"110","author":"Imai","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.02.011_bib275","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.0903306","article-title":"IL-33 induces IL-13-dependent cutaneous fibrosis","volume":"184","author":"Rankin","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib276","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/bmj.327.7425.1222","article-title":"Joining the DoTS: new approach to classifying adverse drug reactions","volume":"327","author":"Aronson","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.trsl.2016.02.011_bib277","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2015.05.027","article-title":"Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy","volume":"136","author":"Wheatley","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib278","doi-asserted-by":"crossref","unstructured":"Blanca-L\u00f3pez N, Torres M, Seoane M, et\u00a0al. Immediate Hypersensitivity Reactions To Quinolones. J Allergy Clin Immunol. 127(2):AB191.","DOI":"10.1016\/j.jaci.2010.12.758"},{"key":"10.1016\/j.trsl.2016.02.011_bib279","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5582\/ddt.2011.v5.5.211","article-title":"Agents that induce pseudo-allergic reaction","volume":"5","author":"Wang","year":"2011","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.trsl.2016.02.011_bib280","unstructured":"Society TM. http:\/\/www.tmsforacure.org 2015."},{"key":"10.1016\/j.trsl.2016.02.011_bib281","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib282","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2885.2007.00911.x","article-title":"Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs","volume":"30","author":"Guedes","year":"2007","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.trsl.2016.02.011_bib283","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1089\/jpm.2008.9817","article-title":"Opioid allergic reactions #175","volume":"11","author":"Woodall","year":"2008","journal-title":"J Palliat Med"},{"key":"10.1016\/j.trsl.2016.02.011_bib284","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0091-6749(84)90447-0","article-title":"Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation","volume":"73","author":"Casale","year":"1984","journal-title":"J Allergy Clin Immunol"},{"issue":"2 Suppl","key":"10.1016\/j.trsl.2016.02.011_bib285","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.trsl.2016.02.011_bib286","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2005.09.069","article-title":"Phospholipase Cbeta1 modulates pain sensitivity, opioid antinociception and opioid tolerance formation","volume":"1069","author":"Liu","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.trsl.2016.02.011_bib287","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000542-200004000-00026","article-title":"Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells","volume":"92","author":"Veien","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.trsl.2016.02.011_bib288","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri1782","article-title":"Integrated signalling pathways for mast-cell activation","volume":"6","author":"Gilfillan","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib289","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s000110050058","article-title":"Morphine and muscle relaxants are receptor-independent G-protein activators and cromolyn is an inhibitor of stimulated G-protein activity","volume":"46","author":"Klinker","year":"1997","journal-title":"Inflamm Res"},{"key":"10.1016\/j.trsl.2016.02.011_bib290","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000542-198905000-00008","article-title":"Wheal and flare responses to opioids in humans","volume":"70","author":"Levy","year":"1989","journal-title":"Anesthesiology"},{"key":"10.1016\/j.trsl.2016.02.011_bib291","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/icb.2015.10","article-title":"Mast cell-MrgprB2: sensing secretagogues or a means to overreact","volume":"93","author":"Grimbaldeston","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.trsl.2016.02.011_bib292","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.02.011_bib293","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/cc1871","article-title":"Red man syndrome","volume":"7","author":"Sivagnanam","year":"2003","journal-title":"Critical Care"},{"key":"10.1016\/j.trsl.2016.02.011_bib294","first-page":"694","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","volume":"19","author":"Bruniera","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.trsl.2016.02.011_bib295","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF01976748","article-title":"Mechanisms of vancomycin-induced histamine release from rat peritoneal mast cells","volume":"40","author":"Horinouchi","year":"1993","journal-title":"Agents Actions"},{"key":"10.1016\/j.trsl.2016.02.011_bib296","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1128\/AAC.43.12.2881","article-title":"Potentiation of vancomycin-induced histamine release by muscle relaxants and morphine in rats","volume":"43","author":"Shuto","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.trsl.2016.02.011_bib297","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.trsl.2016.02.011_bib298","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaip.2014.04.010","article-title":"Management of hypersensitivity reactions to carboplatin and paclitaxel in an outpatient oncology infusion center: a 5-year review","volume":"2","author":"Banerji","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.trsl.2016.02.011_bib299","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2500\/aap.2013.34.3644","article-title":"Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies","volume":"34","author":"White","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.trsl.2016.02.011_bib300","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)\u2014classification, diagnosis and management: review of the EAACI\/ENDA and GA2LEN\/HANNA","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib301","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00128071-200203090-00002","article-title":"NSAID-induced urticaria and angioedema: a reappraisal of its clinical management","volume":"3","author":"Sanchez-Borges","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.trsl.2016.02.011_bib302","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jdv.12658","article-title":"Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria","volume":"29","author":"Sanchez-Borges","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.trsl.2016.02.011_bib303","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jaci.2003.12.323","article-title":"Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma","volume":"113","author":"Mastalerz","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib304","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2008.09.005","article-title":"Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years","volume":"123","author":"Setkowicz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.02.011_bib305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1398-9995.1980.tb01730.x","article-title":"Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review","volume":"35","author":"Settipane","year":"1980","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib306","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","article-title":"Self-reported drug allergy in a general adult Portuguese population","volume":"34","author":"Gomes","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.02.011_bib307","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301753","article-title":"Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease","volume":"193","author":"Steinke","year":"2014","journal-title":"J Immunol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416000657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416000657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T14:19:11Z","timestamp":1748787551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524416000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":307,"alternative-id":["S1931524416000657"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2016.02.011","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging concepts: mast cell involvement in allergic diseases","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2016.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}